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Following the complete sequence elucidation of human pancreatic stone protein (immunoreactive form PSP S1 isolated 
from pancreatic juice) [(1987) Eur. J. Biochem. 168, 201-207], the location of the three S-S bridges of the protein was 
investigated. The cystine-containing peptides, detected after the separation of the peptic or chymotryptic digests on 
SP-Sephadex or Sephadex G-50, were submitted to Edman degradation a d/or to oxidation. The cysteic peptides after 
separation on SP-Sephadex or Sephadex G-50 were characterized by their amino acid compositions. The pairing of the 
half-cystines: Cys 3-Cys 14, Cys 31-Cys 129 and Cys 104-Cys 121 was determined. The same experiments carried out 
with PSP $2-5 (other immunoreactive forms) gave an identical characterization. 
Disulfide bridge; Pancreatic stone protein; (Pancreatic juice, Human) 
1. INTRODUCTION 
Var ious forms of  human pancreat ic  stone pro-  
tein deriving f rom the same native protein,  syn- 
thesized in pancreat ic  acinar cells [1], have been 
revealed: PSP,  the form prepared from calculi [2]; 
PSP  S1 one o f  the immunoreact ive forms (Mr 
15000) [3,4]; and PSP $2-5 ,  other immunoreac-  
tive forms (Mr 16000-19000) detected in pan- 
creatic juice but not separated f rom each other 
[3,4]. Both PSP and PSP S1 have the same Mr as 
well as N-terminal  sequence and C-terminal  
residues [4,5]. PSP  S1 derives f rom PSP $2-5  
through the tryptic cleavage of  an Arg - I le  bond 
[5]. In a recent publ icat ion the total  sequence of  
PSP  S1 was elucidated [6]. The 6 half-cystines of  
the molecule were located at posit ions 3, 14, 31, 
104, 121 and 129 in the al ignment of  the 133 amino 
acid residues of  PSP-S1.  Since no free thiol was 
detected in PSP  S1 [4], the presence of  three 
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disulf ide bridges was assumed. In a preceding 
paper  [5] the first S-S bridge connecting Cys 3 to 
Cys 14 was demonstrated in the course of  an in- 
vest igation per formed in view of  revealing the 
nature of  the bond cleaved in the conversion of  
PSP  $2-5  to PSP S1. The present report  conf irms 
the cystine l inkage between Cys 3 and Cys 14 and 
deals with the assignment of  the two remaining 
bridges. 
2. EXPERIMENTAL 
Most of the methods have been described: preparation of 
PSP SI and PSP $2-5 [4], dansylation [7], succinylation [6], 
amino acid analysis [7,8], automated Edman degradation [6], 
5,5 '-dithiobis(2-nitrobenzoic acid) reaction in the presence of 
10 mM EDTA and 1070 SDS [9], location of the half-cystine- 
containing peptides eluted from column [10] and pepsin diges- 
tion [5]. The chymotryptic digestion was performed on 15 mg 
succinylated PSP $1 or PSP $2-5 in 1 ml of 60 mM NH4HCO3 
buffer (pH 7.8) for 5 h at 37°C (enzyme/substrate, 1:50, w/w). 
The reaction was stopped by adding phenylmethylsulfonyl 
fluoride (1 mM). Thin-layer chromatography on silica gel (TIC 
plates, silica gel 60, Merck) was performed with development in
a solvent system of acetonitrile/water/pyridine (75:20:5, v/v) 
adjusted to pH 6.0 with a few drops of acetic acid. Three suc- 
cessive runs in the same direction were carried out, the plate be- 
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ing dried after each run. The peptides were located using 
ninhydrin reagent (0.05% in acetone) and were extracted with 
water followed by acetonitrile. 
3. RESULTS AND DISCUSSION 
The absence of free thiol in PSP-S1 and PSP- 
$2-5 [4] was confirmed by titration with 
5,5'-dithiobis(2-nitrobenzoic acid) in the presence 
of  EDTA and SDS. Moreover, a mild reduction of 
the proteins with sodium arsenite was performed. 
In the case of SH groups having been partially ox- 
idized into sulfenic or sulfinic radicals, this treat- 
ment would have reconverted them into their 
primitive forms [11]. No SH group was detected 
after this experiment. 
In a previous paper [5], the peptic digest of PSP 
$1 had been filtered on Sephadex G-50 and the 
cystine peptide (1-15) had been easily determined 
being included in a peak separated from the major 
compounds. Here, the peptic digest was 
chromatographed on SP-Sephadex. The half- 
cystine-positive fractions were selected (A-C).  On- 
ly rectangles indicate their positions in the elution 
diagram (fig.l). The study of fraction B did not 
yield any interesting results given the low amount 
of half-cystine included. Fraction A and an aliquot 
of fraction C were performic acid-oxidized (AO 
and CO) and chromatographed on an SP- 
Sephadex column under the same conditions as the 
peptic digest. Only one peak (AO1) containing 
cysteic acid peptide was derived from fraction AO 
(fig.la). Two peaks CO1 and CO2 containing 
cysteic acid peptides were obtained from fraction 
CO (fig.lb). Fractions X and Y contained no 
amino acid after hydrolysis. The amino acid com- 
positions and N-terminal amino acid residue(s) of 
A, AO1, C, CO1 and CO2 are listed in table 1. 
Moreover, the N-terminal sequence of an aliquot 
of fraction C was performed using automated Ed- 
man degradation. Two chains were simultaneously 
degraded (fig.2). The non-characterization f the 
derivative at step 2 for the two chains was due to 
the presence of half-cystine residues. All these 
results demonstrated that cystine linkages exist be- 
tween Cys 3 and Cys 14 (confirmation of the 
results in [5]) as well as between Cys 31 and Cys 
129. 
Having coupled 4 haif-cystines out of 6, it is 
logical to assume that the two remaining half- 
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Fig. 1. Chromatography of the oxidized peptic peptides A and 
C (AO, CO) on SP-Sephadex C-25. (a) Fraction AO, (b) 
fraction CO. Rectangles (more or less shaded according to the 
cystine concentration) i dicates the place of cystine-containing 
fractions in the elution of the peptic hydrolysate of PSP SI 
(400 nmol) chromatographed un er the same conditions. The 
column (0.6 × 35 cm) was equilibrated with 5 mM pyridine- 
acetate buffer (pH 2.5) and eluted with 4 successive gradients of
increasing pH and pyridine concentration. I (5 mM, pH 2.4 to 
0.1 M, pH 3.75); II (0.1 M, pH 3.75 to 0.4 M, pH 4.8); Ill 
(0.4 M, pH 4.8 to 0.8 M, pH 5.0); IV (0.8 M, pH 5.0 to 4 M, 
pH 5.8). Only the first two gradients were necessary for these 
chromatography steps, the volume of each of the two gradient 
chambers was 80ml, the flow rate 9.1 ml/h and 1.3-ml 
fractions were collected at room temperature. Eluants were 
monitored by ninhydrin assay after alkaline hydrolysis. 
cystines Cys 104 and Cys 121 are linked. In the 
above experiment this cystine compound was not 
found. The peptide cleavages might not have been 
specific enough in this area to give a cystine pep- 
tide in a good yield. Therefore, chymotryptic 
hydrolysis of succinylated PSP S 1 was carried out. 
Succinylation of PSP SI was performed to ensure 
the solubility of the hydrolysate. The digest was 
filtered on Sephadex G-50 (fig.3). Fractions I - I I I  
after oxidation contained cysteic acid peptides. 
Since in fractions II and I I I  it was possible to 
detect peptides of the S-S bridges 1-14 and 
104-121 respectively, only fraction I was in- 
vestigated. 
As anticipated the latter was cystine-positive. 15 
steps of automatic Edman degradation were per- 
formed on an aliquot of fraction I. Two chains 
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were sequenced (fig.2). Chain 1 contained more 
than 15 amino acid residues. It was sequenced 
from residue 92 to 106. Chain 2 was made up of 9 
amino acid residues in position 117-125 of the 
PSP S1 sequence. The two non-identified 
derivatives correspond to Cys 104 and Cys 121. 
A fur ther  conf i rmat ion  o f  the  ex is tence o f  the  
br idge  l ink ing  Cys  104 to  Cys 121 was  g iven  by  the  
fo l low ing  exper iment :  an  a l iquot  o f  f rac t ion  I was  
ox id i zed  ( IO)  and  chromatographed on  a th in  layer  
o f  s i l ica gel. Two spots  IO1 and  IO2  migrat ing  as 
Lys  and  Val ,  respect ive ly ,  were  obta ined  (f ig.3).  
Table 1 
Amino acid composition and characteristics of the cystine-containing peptides and their oxidation products 
Amino acids A AOI Sequence C COl Sequence CO2 Sequence I IO1 Sequence IO2 Sequence 
1-15 30-39 128-133 117-125 92-107 
Cys 1.5 1.6 2 1.5 1.0 1 1.1 1 2.0 
Asx 1.0 0.9 1 3.8 3.0 3 1.0 1 3.1 
Met (02) 1.2 0.8 1 
Thr 0.8 0.6 1 0.9 
Ser 1.8 2.0 2 1.1 1.0 1 4.0 
GIx 1.0 1.1 1 1.1 1.1 1 2.6 
Pro 1.1 1.2 1 1.9 
Gly 1.1 1.0 1 1.0 1.0 1 3.1 
Ala 1.1 1.0 1 2.2 
Val 1.0 1.1 1 2.6 
Ile 0.9 0.8 1 1.0 
Leu 0.9 1.0 1 0.9 
Tyr 2.1 2.1 3 1.0 0.9 1 0.5 
Phe 0.9 0.9 1 1.5 
His 
Lys 2.2 1.7 2 2.6 
Arg 1.0 1 
Total residue 15 10 6 
Recovery (070) 78 15 43 9 14 12 
N-terminal Ile Ile lie Tyr Tyr Tyr Val Val Gly 
residue(s) Val Lys 
0.6 1 0.9 1 
2.2 2 1.1 1 
1.3 1 
0.8 1 
0.9 1 
3.0 3 
1.9 2 
3.0 3 
1.0 1 
3.2 2 
0.5 1 
1.0 1 
ND 1 
1.0 1 
1.7 2 
9 
6 2 
ND Lys ND 
16 
Gly 
All analyses were made after performic acid oxidation of the compounds. Cys and Met were titrated as cysteic acid and methionine 
sulfone. Oxidized tyrosine gave one or two peaks of low yield eluting between Phe and His. Experimental values are data of 24 h 
hydrolysis without corrections for losses 
Steps 
-Fraction C 
Chain l 
Chain 2 
-Fract ion I 
Chain l 
Chain 2 
1 2 3 4 5 6 7 8 9 I0 I I  12 13 14 15 
Tyr - - -  Gin Asn Met Asn Ser Gly Asn Leu . . . . . .  ( 30- 39) 
Val - - -  Lys Phe Lys Asn . . . . . . . . . . . . . . . . . .  (128-133) 
Gly l le  Gly Ala Pro Ser Ser Val Asn Pro Gly Tyr - - -  Val Ser (92-I06) 
Lys Asp Val Pro - - -  Glu Asp Lys Phe . . . . . . . . . . . . . . . . . .  (I17-125) 
Fig.2. Automated Edman degradations of the half-cystine-containing peptides in fractions C and I. 12 and 15 steps were performed 
for fractions C and I, respectively. For fraction C, initial amount was 5 nmol and initial and repetitive yields 18 and 91070. For fraction 
I: initial amount was 3 nmol and initial and repetitive yields 34 and 84070. 
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Fig.3. Gel filtration on Sephadex G-50 (superfine) of the 
chymotryptic digestion of the succinylated PSP SI. Two 
columns (1.5 x 100cm) were connected in series and 
equilibrated and eluted at room temperature with 60 mM 
ammonium bicarbonate buffer (pH 7.8). Flow rate 12 ml/h. 
2 ml fraction volume. Absorbances were measured at 230 nm 
( ) and 280 nm ( - - - ) .  Shaded areas: fractions containing 
cysteic acid after oxidation. Above peak I, TLC of the peak I
fractions after oxidation is illustrated. 
-Arg!lle-Ser-C~s-Pro-Glu-Gly-Thr-Asn-Ala-Tyr-Arg-Ser-Tyr-Cyls-~5r - 
30 l---- 
Tyr . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Tyr-Cys- 
39 
Gln-Asn-Met-Asn-Ser-Gly-Asn-Leu . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
92 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Gly-lle-Gly-A1 a-Pro- 
Ser-Ser-Val-Asn-Pro-G1y-Tyr-Cys-Val-Ser-Leu-Thr-Ser-Ser-Thr- 
i 
I16 117 ~ 125 
Gly-Phe-Gln-Lys-Trp-Lys-Asp-Va|-Pro-Cys-Glu-Asp-Lys-Phe . . . . .  
128 133 
. . . .  Val-Cys-Lys-Phe-Lys-Asn- 
t 
Fig.4. Schematic representation f the polypeptide chain of 
PSP S1 showing the location of its three disulfide bridges: Cys 
3-Cys 14, Cys 31-Cys 129 and Cys 104-Cys 121. The arrow 
indicates the bond cleavage converting the polypeptide chain of 
PSP $2-5 into that of PSP S1. 
REFERENCES 
The amino acid composit ions of these peptides 
(table 1) enabled their identif ication with peptide 
sequences 117-125 and 92-107, respectively. The 
amino acid composit ion of 102 was not as satisfac- 
tory as that of IO1 on account of the small quanti-  
ty of this peptide available for the determination. 
In fig.4, the three S-S bridges of PSP S1 are 
represented. The N- and C-terminal sequences are 
held together by the disulfide bond connecting Cys 
31 to Cys 129. The two other disulfide bonds link- 
ing Cys 3 to Cys 14 and Cys 104 to Cys 121 only 
form small loops in the protein sequence. The 
same experiments as those described above for 
PSP SI were performed on the forms PSP $2-5  
and identical S-S bridges were found. 
Acknowledgements: We thank Mrs Andrea Guidoni for the 
amino acid analyses and Mrs Mireille Woudstra for the amino 
acid sequence determinations. We are grateful to Mrs Vera 
Stefani Martin for reviewing the English text. 
[1] LechSne de la Porte, P., De Caro, A., Lafont, H. and 
Sarles, H. (1986) Pancreas 1, 301-308. 
[2] De Caro, A., Lohse, J. and Sarles, H. (1979) Biochem. 
Biophys. Res. Commun. 87, 1176-1182. 
[3] Montalto, G., Lusher, M., De Caro, A., Multigner, L., 
Sarles, H. and Delaage, M. (1985) CR Acad. Sci. SeE III 
300, 199-202. 
[4] Montalto, G., Bonicel, J., Multigner, L., Rovery, M., 
Sarles, H. and De Caro, A. (1986) Biochem. J. 238, 
227-232. 
[5] Rouimi, P., Bonicel, J., Rovery, M. and De Caro, A. 
(1987) FEBS Lett. 216, 195-199. 
[6] De Caro, A.M., Bonicel, J.J., Rouimi, P., De Caro, 
J.D., Sarles, H. and Rovery, M. (1987) Eur. J. Biochem. 
168, 201-207. 
[7] Bianchetta, J.D., Bidaud, J., Guidoni, A.A., Bonicel, 
J.J. and Rovery, M. (1979) Eur. J. Biochem. 97, 
395-405. 
[8] De Caro, J.D., Behnke, W.D., Bonicel, J.J., Desnuelle, 
P.A. and Rovery, M. (1983) Biochim. Biophys. Acta 747, 
253-262. 
[9] Ellman, G.L. (1959) Arch. Biochem. Biophys. 82, 70-77. 
[10] Erlanson, C., Charles, M., Astier, M. and Desnuelle, P. 
(1974) Biochim. Biophys. Acta 359, 198-203. 
[11] Le Galliard, F. and Dautrevaux, M. (1978) FEBS Lett. 94, 
63-67. 
174 
